MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Direct Targeting of the VIM Nucleus during High Intensity Focused Ultrasound (HIFU) by Direct Visualization

    Z. Zibly, S. Israeli Korn (Ramat Gan, Israel)

    Objective: To determine the “functional” target within  VIM Nucleus of the Thalamus during HIFU with high field MRI. Background: Targeting of neuronal structures has been…
  • MDS Virtual Congress 2020

    Sustained Improvement in Freezing of Gait (FOG) and Treatment Satisfaction at 12 months After Initiation of Carbidopa/Levodopa Enteral Suspension (CLES) in Advanced Parkinson’s Disease (APD) Patients in USA: Interim Results from the PROviDE Study

    R. Pahwa, S. Isaacson, B. Bluett, P. Kandukuri, N. Gupta, Y. Jalundhwala, P. Kukreja, I. Pan, J. Aldred (North Chicago, IL, USA)

    Objective: To evaluate the long-term effectiveness of CLES on FOG and treatment satisfaction in APD patients. Background: FOG, prevalent in about 60% of APD patients,…
  • 2019 International Congress

    The Dutch Parkinson and Cognition study (DUPARC): Cognitive impairment and cholinergic innervation in de novo Parkinson’s Disease patients

    S. Vander Zee, JM. Boertien, MJJ. Gerritsen, JM. Spikman, T. van Laar (Groningen, Netherlands)

    Objective: To explore the incidence and characteristics of early cognitive impairment in Parkinson’s disease (PD) patients and the relationship with regional cholinergic innervation. Background: Cognitive…
  • 2019 International Congress

    Neuroimaging in Parkinson’s disease dementia: Connecting the dots

    R. Weil, J. Hsu, R. Darby, L. Soussand, M. Fox (Nashville, TN, USA)

    Objective: To identify the neural substrates of Parkinson’s disease dementia (PDD) and Parkinson’s disease with Mild Cognitive Impairment (PD-MCI) using a network mapping approach. Background:…
  • 2019 International Congress

    Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s Disease: An in vivo [11C]BU99008 PET study

    H. Wilson, G. Dervenoulas, G. Pagano, R. Tyacke, J. Myers, R. Gunn, E. Rabiner, D. Nutt, M. Politis (London, United Kingdom)

    Objective: We aimed to evaluate the role of astroglia activation in Parkinson's disease (PD) using [11C]BU99008 PET, a novel radioligand with high specificity and selectivity…
  • 2019 International Congress

    Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Huntington’s Disease: An in vivo [11C]BU99008 PET study

    H. Wilson, F. Niccolini, G. Dervenoulas, R. Tyacke, J. Myers, R. Gunn, D. Nutt, E. Rabiner, S. Tabrizi, M. Politis (London, United Kingdom)

    Objective: We aimed to evaluate the role of astroglia activation in Huntington’s disease gene expansion carriers (HDGECs) using [11C]BU99008 PET, a novel radioligand with high specificity and…
  • 2019 International Congress

    The role of Synaptic vesicle protein 2A (SV2A) in patients with Parkinson’s disease dementia and Dementia with Lewy bodies: An in vivo [11C]UCB-J PET study

    H. Wilson, G. Dervenoulas, G. Pagano, A. Chandra, F. Niccolini, M. Esposito, R. Gunn, L. Ricciardi, E. Rabiner, D. Aarsland, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate the role of synaptic vesicle glycoprotein 2A (SV2A) in Parkinson’s disease dementia (PDD) and Dementia with Lewy bodies (DLB) using…
  • 2019 International Congress

    Regional subcortical volumes predict gait decline in early Parkinson’s disease

    J. Wilson, R. Lawson, B. Galna, A. Yarnall, S. Lord, R. Morris, L. Alcock, G. Duncan, T. Khoo, D. Burn, L. Rochester, J-P. Taylor (Newcastle Upon Tyne, United Kingdom)

    Objective: To predict changes in discrete gait characteristics in early Parkinson’s disease (PD) compared to healthy ageing, using subcortical brain volumes quantified in early disease.…
  • 2019 International Congress

    Distributed Global Functional Connectivity Networks Predict Responsiveness to L-DOPA and Subthalamic Deep Brain Stimulation

    C. Wu, T. Foltynie, P. Limousin, L. Zrinzo, H. Akram (Philadelphia, PA, USA)

    Objective: To investigate global resting-state functional connectivity (rsFC) patterns associated with response to L-DOPA and to subthalamic nucleus (STN) deep brain stimulation (DBS) in patients…
  • 2019 International Congress

    The neural representations of the voice tremor spectrum

    L. Xavier, K. Simonyan (Boston, MA, USA)

    Objective: Investigate shared and disorder-specific brain abnormalities in essential and dystonic tremor of voice using functional and structural brain imaging. Background: Essential tremor of voice…
  • « Previous Page
  • 1
  • …
  • 978
  • 979
  • 980
  • 981
  • 982
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley